TTNP logo

Titan Pharmaceuticals (TTNP) Current Assets

Annual Current Assets

$8.02 M
+$4.42 M+122.54%

31 December 2023

TTNP Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$4.35 M
-$2.26 M-34.20%

30 June 2024

TTNP Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTNP Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+122.5%-56.1%
3 y3 years+9.4%-50.8%
5 y5 years-39.7%+10.2%

TTNP Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+122.5%-56.1%+773.5%
5 y5 years-39.7%+122.5%-67.0%+773.5%
alltimeall time-93.2%+701.8%-96.3%+773.5%

Titan Pharmaceuticals Current Assets History

DateAnnualQuarterly
June 2024
-
$4.35 M(-34.2%)
Mar 2024
-
$6.61 M(-17.5%)
Dec 2023
$68.00 K(-85.1%)
$8.02 M(-19.0%)
Sept 2023
-
$9.90 M(+1887.8%)
June 2023
-
$498.00 K(-72.1%)
Mar 2023
-
$1.78 M(-50.5%)
Dec 2022
$455.00 K(-40.5%)
$3.60 M(-37.3%)
Sept 2022
-
$5.75 M(-25.5%)
June 2022
-
$7.71 M(-19.9%)
Mar 2022
-
$9.63 M(+33.3%)
Dec 2021
$765.00 K(+0.8%)
$7.23 M(-18.3%)
Sept 2021
-
$8.85 M(-16.8%)
June 2021
-
$10.63 M(-19.4%)
Mar 2021
-
$13.19 M(+80.0%)
Dec 2020
$759.00 K(-37.5%)
$7.33 M(+10.2%)
Sept 2020
-
$6.65 M(-23.5%)
June 2020
-
$8.69 M(-28.5%)
Mar 2020
-
$12.15 M(+46.2%)
Dec 2019
$1.21 M(+52.9%)
$8.31 M(+110.5%)
Sept 2019
-
$3.95 M(-28.2%)
June 2019
-
$5.49 M(-45.6%)
Mar 2019
-
$10.09 M(-24.1%)
Dec 2018
$794.00 K(+33.4%)
$13.30 M(+15.4%)
Sept 2018
-
$11.53 M(+174.9%)
June 2018
-
$4.19 M(-11.7%)
Mar 2018
-
$4.75 M(-42.9%)
Dec 2017
$595.00 K(-28.9%)
$8.31 M(-31.1%)
Sept 2017
-
$12.06 M(+37.7%)
June 2017
-
$8.75 M(-28.9%)
Mar 2017
-
$12.31 M(-30.9%)
Dec 2016
$837.00 K(-19.8%)
$17.83 M(-21.4%)
Sept 2016
-
$22.68 M(-7.0%)
June 2016
-
$24.39 M(+122.0%)
Mar 2016
-
$10.99 M(-10.2%)
Dec 2015
$1.04 M(-17.7%)
$12.24 M(-11.6%)
Sept 2015
-
$13.85 M(-14.6%)
June 2015
-
$16.21 M(-5.7%)
Mar 2015
-
$17.20 M(-12.2%)
Dec 2014
$1.27 M(-20.9%)
$19.58 M(+65.1%)
Sept 2014
-
$11.86 M(-7.4%)
June 2014
-
$12.81 M(-12.3%)
Mar 2014
-
$14.61 M(-13.2%)
Dec 2013
$1.60 M(+15.2%)
$16.82 M(+21.4%)
Sept 2013
-
$13.85 M(-9.1%)
June 2013
-
$15.23 M(-30.7%)
Mar 2013
-
$21.96 M(-6.3%)
Dec 2012
$1.39 M(+445.9%)
$23.43 M(+149.8%)
Sept 2012
-
$9.38 M(+6.4%)
June 2012
-
$8.82 M(+30.9%)
Mar 2012
-
$6.74 M(-32.4%)
Dec 2011
$255.00 K(+381.1%)
$9.96 M(+54.0%)
Sept 2011
-
$6.47 M(-26.1%)
June 2011
-
$8.75 M(+175.6%)
Mar 2011
-
$3.17 M(-32.4%)
Dec 2010
$53.00 K
$4.70 M(-44.6%)
DateAnnualQuarterly
Sept 2010
-
$8.49 M(+321.8%)
June 2010
-
$2.01 M(-72.7%)
Mar 2010
-
$7.36 M(+103.6%)
Dec 2009
$110.00 K(-71.6%)
$3.62 M(-72.5%)
Sept 2008
-
$13.17 M(-31.0%)
June 2008
-
$19.08 M(-24.6%)
Mar 2008
-
$25.32 M(-16.9%)
Dec 2007
$388.00 K(-52.7%)
$30.46 M(+118.5%)
Sept 2007
-
$13.94 M(-23.2%)
June 2007
-
$18.16 M(+62.6%)
Mar 2007
-
$11.16 M(-21.5%)
Dec 2006
$821.00 K(-28.7%)
$14.22 M(-20.4%)
Sept 2006
-
$17.86 M(-14.0%)
June 2006
-
$20.76 M(-13.9%)
Mar 2006
-
$24.12 M(+29.8%)
Dec 2005
$1.15 M(-3.5%)
$18.59 M(-7.2%)
Sept 2005
-
$20.02 M(-21.1%)
June 2005
-
$25.37 M(-20.6%)
Mar 2005
-
$31.97 M(-14.6%)
Dec 2004
$1.19 M(+9.6%)
$37.43 M(-15.6%)
Sept 2004
-
$44.37 M(-10.8%)
June 2004
-
$49.74 M(-12.9%)
Mar 2004
-
$57.13 M(+19.2%)
Dec 2003
$1.09 M(-14.9%)
$47.92 M(-13.1%)
Sept 2003
-
$55.17 M(-10.3%)
June 2003
-
$61.50 M(-9.7%)
Mar 2003
-
$68.10 M(-8.8%)
Dec 2002
$1.28 M(+8.9%)
$74.65 M(-9.8%)
Sept 2002
-
$82.74 M(-8.9%)
June 2002
-
$90.82 M(-6.9%)
Mar 2002
-
$97.59 M(-7.9%)
Dec 2001
$1.18 M(+98.1%)
$105.96 M(-3.6%)
Sept 2001
-
$109.89 M(-3.5%)
June 2001
-
$113.89 M(-1.2%)
Mar 2001
-
$115.28 M(-2.2%)
Dec 2000
$593.00 K(+18.6%)
$117.85 M(+47.2%)
Sept 2000
-
$80.08 M(-3.5%)
June 2000
-
$82.98 M(-2.7%)
Mar 2000
-
$85.33 M(+81.9%)
Dec 1999
$500.00 K(+25.0%)
$46.90 M(+404.3%)
Sept 1999
-
$9.30 M(-22.5%)
June 1999
-
$12.00 M(-20.0%)
Mar 1999
-
$15.00 M(+27.1%)
Dec 1998
$400.00 K(+33.3%)
$11.80 M(-19.7%)
Sept 1998
-
$14.70 M(-15.5%)
June 1998
-
$17.40 M(-12.1%)
Mar 1998
-
$19.80 M(-21.7%)
Dec 1997
$300.00 K(-82.4%)
$25.30 M(+232.9%)
Sept 1997
-
$7.60 M(-42.9%)
June 1997
-
$13.30 M(+62.2%)
Mar 1997
-
$8.20 M(-44.2%)
Dec 1996
$1.70 M(-54.1%)
$14.70 M(-16.5%)
Sept 1996
-
$17.60 M(+170.8%)
June 1996
-
$6.50 M(-30.1%)
Mar 1996
-
$9.30 M(+830.0%)
Dec 1995
$3.70 M
$1.00 M

FAQ

  • What is Titan Pharmaceuticals annual total current assets?
  • What is the all time high annual current assets for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals annual current assets year-on-year change?
  • What is Titan Pharmaceuticals quarterly total current assets?
  • What is the all time high quarterly current assets for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals quarterly current assets year-on-year change?

What is Titan Pharmaceuticals annual total current assets?

The current annual current assets of TTNP is $8.02 M

What is the all time high annual current assets for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high annual total current assets is $117.85 M

What is Titan Pharmaceuticals annual current assets year-on-year change?

Over the past year, TTNP annual total current assets has changed by +$4.42 M (+122.54%)

What is Titan Pharmaceuticals quarterly total current assets?

The current quarterly current assets of TTNP is $4.35 M

What is the all time high quarterly current assets for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high quarterly total current assets is $117.85 M

What is Titan Pharmaceuticals quarterly current assets year-on-year change?

Over the past year, TTNP quarterly total current assets has changed by -$5.55 M (-56.06%)